Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Inflammation and the brain

A Compston1

  • 1University of Cambridge Clinical School, Addenbrooke's Hospital, UK.

Molecular and Chemical Neuropathology
|May 1, 1993
PubMed
Summary
This summary is machine-generated.

Brain inflammation damages myelin, causing conditions like multiple sclerosis. Immune cells and cytokines drive this demyelination, suggesting immunological treatments could help patients.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Acting on incidental findings in research imaging.

BMJ (Clinical research ed.)·2015
Same author

Exome sequencing in single cells from the cerebrospinal fluid in multiple sclerosis.

Multiple sclerosis (Houndmills, Basingstoke, England)·2014
Same author

Genetic burden in multiple sclerosis families.

Genes and immunity·2013
Same author

Efficient derivation of NPCs, spinal motor neurons and midbrain dopaminergic neurons from hESCs at 3% oxygen.

Nature protocols·2011
Same author

Derivation of neural precursor cells from human ES cells at 3% O(2) is efficient, enhances survival and presents no barrier to regional specification and functional differentiation.

Cell death and differentiation·2011
Same author

Exploring the CLEC16A gene reveals a MS-associated variant with correlation to the relative expression of CLEC16A isoforms in thymus.

Genes and immunity·2010
Same journal

Alterations in free radical scavenger system profile of type I diabetic rat brain.

Molecular and chemical neuropathology·1999
Same journal

A light and electron microscopic study of the metabotropic glutamate receptor mGluR1a in the normal and kainate-lesioned rat hippocampus.

Molecular and chemical neuropathology·1999
Same journal

Localization of GTPase-activating protein-(GAP) like immunoreactivity in mouse cerebral regions.

Molecular and chemical neuropathology·1999
Same journal

L-deprenyl induces aromatic L-amino acid decarboxylase (AADC) mRNA in the rat substantia nigra and ventral tegmentum. An in situ hybridization study.

Molecular and chemical neuropathology·1999
Same journal

The effect of 4 beta-phorbol-12,13-dibutyrate and staurosporine on the extracellular glutamate levels during ischemia in the rat striatum.

Molecular and chemical neuropathology·1999
Same journal

The impact of diabetes on CNS. Role of bioenergetic defects.

Molecular and chemical neuropathology·1999
See all related articles

Area of Science:

  • Neuroimmunology
  • Central Nervous System Disorders

Background:

  • Inflammation in the brain selectively damages the myelin sheath, leading to neurological syndromes such as multiple sclerosis.
  • Magnetic resonance imaging (MRI) can identify areas of inflammation and demyelination in these disorders.
  • T-cell activation at the blood-brain barrier enhances immune surveillance within the central nervous system (CNS).

Purpose of the Study:

  • To elucidate the mechanisms of inflammatory demyelination in the CNS.
  • To explore the role of T-cells, cytokines, and glial cells in myelin damage.
  • To provide a rationale for immunological treatments in multiple sclerosis.

Main Methods:

  • Review of clinical and experimental studies on brain inflammation and demyelination.
  • Analysis of T-cell activation, cytokine release, and glial cell interactions.

Related Experiment Videos

  • Examination of immune cell (macrophage, microglia) involvement in myelin removal.

    • Main Results:

    • Persistent T-cells activated against brain antigens create conditions for inflammatory demyelination.
    • Local cytokine release contributes to the removal of oligodendrocytes and myelin by macrophages/microglia.
    • Microglial receptors for antibody and complement components mediate interactions with target cells.

    Conclusions:

    • The pathogenesis of demyelinating diseases involves complex interactions between immune cells and CNS components.
    • Understanding these interactions supports the development of targeted immunological therapies for multiple sclerosis.
    • Further research into neuroinflammatory pathways is crucial for advancing treatment strategies.